Market Tracker

05/26 5:16pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.239
Delayed Data
As of May 26
 +0.014 / +6.22%
Today’s Change
0.20
Today|||52-Week Range
0.64
-32.73%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.23
Today’s open0.23
Day’s range0.21 - 0.24
Volume510,322
Average volume (3 months)284,056
Market cap$21.0M
Dividend yield--
Data as of 3:59pm ET, 05/26/2016

Growth & Valuation

Earnings growth (last year)+6.25%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.94

Competitors

 Today’s
change
Today’s
% change
ABACAoxin Tianli Group I...0.000.00%
HTGMHTG Molecular Diagno...0.000.00%
--Protea Biosciences G...+0.02+8.33%
OPGNOpGen Inc-0.09-6.58%
Data as of 3:59pm ET, 05/26/2016

Financials

Next reporting dateAugust 4, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$0.00
Annual profit (last year)-$12.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Andrew Gengos
Principal Financial &
Accounting Officer
David E. Fractor
Corporate headquarters
Calabasas, California

Forecasts